← All organizations

Imago BioSciences

For profitWebsite ↗

Also known as: Imago BioSciences | Imago BioSciences,Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2022

Acquired by Merck on Nov 21, 2022

Timeline

2010s

Jun 1, 2012
Imago BioSciences— Founded

2020s

Nov 21, 2022
Merck— Acquired By

Drugs by trial phase (4 distinct, 10 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT05558696Study directorPhase 2Dec 31, 2022
NCT05558696Lead sponsorPhase 2Dec 31, 2022
NCT05597306CollaboratorPhase 1Nov 19, 2022
NCT05569538CollaboratorPhase 2Nov 1, 2022
NCT05191797CollaboratorPhase 1/Phase 2Apr 11, 2022
NCT05223920Lead sponsorPhase 2Dec 16, 2021
NCT05223920Study directorPhase 2Dec 16, 2021
NCT04262141CollaboratorPhase 2May 31, 2020
NCT04254978Lead sponsorPhase 2Apr 30, 2020
NCT04081220CollaboratorPhase 2Oct 31, 2019
NCT03136185Lead sponsorPhase 1May 1, 2017
NCT02842827Lead sponsorPhase 1Oct 1, 2016

Details

Founded: San Carlos, CA, US Jun 1, 2012
Last known activity: Dec 31, 2022

Notes

No evidence still extant